Day: May 11, 2023

MONTRÉAL, May 11, 2023 (GLOBE NEWSWIRE) — Goldstar Minerals Inc. (“Goldstar” or the “Corporation”) (TSX-V: GDM) has entered into a Purchase and Sale Agreement (the “Agreement”) for the acquisition of 8 claims (the “IMV Project”) located in the Montérégie region of southern Québec. The claims cover an area of approximately 481.05 hectares (4.81 km²).

The Agreement dated January 27, 2023 provides for the following:

The name of the Corporation would be changed to Green Mining Innovation, the trading symbol would become GMI, and the Corporation will adopt an ecological, innovative and environmentally friendly approach to work.

In an arm’s length transaction, the Corporation will issue 18 million shares to the current owners (“Owners”) of the IMV Project at a deemed price of $0.08 per share and will pay in shares a finder’s fee of 5% equivalent to 900,000 shares.

The Corporation would proceed with a non-brokered private placement for $500,000 consisting of 8,333,333 units, at a price of CDN $0.06 per unit. Each unit will consist of one common share and one purchase warrant where each warrant shall entitle the holder thereof to subscribe for one additional common share at an exercise price of CDN $0.12 at any time until two years after closing.

The warrants will provide for an acceleration clause if the shares trade above a specified price for more than 20 consecutive days. With respect to subscriptions originating from a qualified intermediary, the Company may pay in cash a fee equal to 7% of the subscribed amount.

The private placement use of proceeds will be for transaction expenses (stock exchange fees, legal fees, geology consultant fees) and for exploration expenses to be incurred on the Corporation’s IMV Project. The private placement will not be a Related Party Transaction and the Owners will not participate in the placement.

The Owners of the IMV Project will have 3 representatives on the board of directors of the Corporation, these being the following individuals:

Mr. André Gagné, Mr. Jacques Tremblay and Mr. Daniel Routhier. At closing, Mr. Gagné will become President and CEO, and Mr. Tremblay will become COO, Chief Operating Officer.

ANDRÉ GAGNÉ

Mr. Gagné has acted as a turnaround specialist for all types of businesses, in various business sectors. His great qualities as a manager and negotiator are based on an inclusive approach aimed at balance and consensus between the parties involved. At the end of the negotiation, he presents a Marketing strategy based on the PEB communication strategy which will benefit all those involved in the negotiation.

Mr. Gagné has more than 15 years of experience in the global mining industry, having held senior management positions in this sector. As CEO / PDG of Komet Resources Africa from 2013 to 2019, he led efforts to strengthen the company’s strategic position and the reopening of the Guiro underground mine in Burkina Faso. Before joining Komet Resources Africa, Mr. Gagné was CEO / PDG of Robex Inc. from 2008 to 2013. After restructuring the company, he also launched the Nampala mine project in Mali, which currently produces more than 40,000 ounces of gold per year.

He is a recognized businessman who has, to date, carried out more than 20 company financings, with a total value exceeding 44 million dollars hard cash on the stock markets. Mr. Gagné studied in Consumer Affairs at Laval University in Quebec city

JACQUES TREMBLAY

Mr Tremblay is a mining engineer graduated from Laval University with over 40 years of project development and mine operations management experience, including 20 years in West Africa.

Jacques was most recently with Solutions BF as a mining consultant involved in projects in Burkina Faso, Guinea and Mali. Previously Jacques was COO for KOMET Resources in Burkina Faso, COO for ArcelorMittal Mining in Algeria, Project Manager-West Africa for Dumas Contracting and Director Operations-Maintenance for Nordgold in Burkina Faso and General Manager for the Kamoto underground mine for Glencore in RDC.

DANIEL ROUTHIER

For 30 years, Mr. Daniel Routhier, construction and environmental electrical contractor, has been the owner and director of DANPLEX Inc., which has 25 employees and specializes in construction electricity. He has developed extensive entrepreneurial expertise in this field, covering various aspects such as the design, installation and maintenance of electrical systems, the environmental impact of installations, the manufacture of equipment on site and communication networks.

The company also has a lot of experience in mining resources, having worked for companies such as Rio Tinto, Agnico Eagle, Suncor, Osisko, Stornoway Diamonds, ArcelorMittal, as well as for Hydro-Québec in James Bay and in the greater Northern Quebec.

Mr. Jacques Marchand, consulting engineer in geology, has prepared a geological memorandum on the eight mining claims comprising the IMV Project. The original reports dated March 8 and March 18, 2023 are in French and translations can be consulted below.

document of March 8 https://greenmininginnovation.ca/wp-content/uploads/2023/04/Rp-JM-TSX_en_4.4.23.pdf

document of March 18
https://greenmininginnovation.ca/wp-content/uploads/2023/04/Rp.a-JM-TSX.q_en _4.4.23.pdf

A geological report on the surrounding area available from SIGEOM can also be consulted below.

document of April 5 2013
https://greenmininginnovation.ca/wp-content/uploads/2023/04/Rap1_Charbonneau_eng_2013_43-101_GM68021.pdf

An interest-free loan of $328,000 provided by a shareholder of the Corporation would be converted into shares (not units) at a price to be determined after resumption of trading. As this transaction is a related party transaction under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions – ( “MI 61-101” ) the Corporation will be relying upon the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101.

The Corporation also intends to pursue exploration work on other properties:

Fortune (Gaspé Peninsula), Panache North (Windfall Lake) and Prince (Newfoundland).

Closing is subject to regulatory approval.

It is expected that resumption of trading will occur on or about May 15, 2023.

Web

Newsletter

Facebook

YouTube

LinkedIn

For further information, please contact:
David Crevier
Chairman
Telephone: 514-949-6820
dcrevier@goldstarminerals.com

André Gagné
CEO of Green Mining Innovation
Telephone : 581-983-6815
CEO@greenmininginnovation.ca

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors discussed in the management discussion and analysis section of our interim and most recent annual financial statement or other reports and filings with the TSX Venture Exchange and applicable Canadian securities regulations. We do not assume any obligation to update any forward-looking statements, except as required by applicable laws.

GlobeNewswire Distribution ID 8836830

RIB Software, a multinational providing innovative technology solutions to the architecture, engineering and construction (AEC) industry, has partnered with Building Transparency, a non-profit organisation that has developed a free and open access tool targeted at reducing the impact of embodied carbon and making the industry more efficient and sustainable.

RIB BACKS EMBODIED CARBON MEASUREMENT TECHNOLOGY TO IMPROVE THE BUILDING INDUSTRY’S SUSTAINABILITY

RIB Software, a multinational providing innovative technology solutions to the architecture, engineering and construction (AEC) industry, has partnered with Building Transparency, a non-profit organisation that has developed a free and open access tool targeted at reducing the impact of embodied carbon and making the industry more efficient and sustainable.

Building Transparency’s premier technology solution is the Embodied Carbon in Construction Calculator (EC3). This tool houses a database of digital, third-party verified Environmental Product Declarations (EPDs), which can be used to perform sustainability benchmarking and assessments.

This is particularly useful to construction material procurers, developers, contractors, and policymakers alike. By being able to measure the amount of embodied carbon within production materials, these stakeholders are empowered to evaluate a project’s overall carbon emissions and utilise that information to procure low-carbon material alternatives or, in the case of regulators, set embodied carbon limits.

Addressing the building industry’s environmental impact

The statistics paint an unflattering picture of the AEC industry’s impact on the environment. Research by the Global Alliance for Buildings and Construction (GlobalABC) has uncovered that an estimated 37% of global energy consumption can be attributed to building and construction activities. While the processing of materials such as concrete is believed to contribute to as much as 9% of global carbon dioxide emissions. The high amounts of material waste that occur within the industry along with the need to rework construction structures add to the inefficiencies.

Working in a sustainable manner is critical to the future prosperity of the world. The continued disregard for the negative and potentially disastrous effects of greenhouse-gas emissions, pollutants and other environmentally unsafe practices must be addressed.

Partnership speaks to core purposes 

“There is a need to actionably and urgently reduce the carbon footprint of the AEC industry. Knowledge is power and integrating technology such as EC3 into the workings of the sector provides critical decision-makers with the tools and data needed to effectively evaluate and understand the true carbon footprint associated with their projects. Armed with this, they will be able to chart tangible targets and collectively help minimise the industry’s impact on the environment. We all have a role to play in building a more sustainable world,” says Stacy Smedley, Executive Director of Building Transparency.

“Throughout our 60-year history, transformative digital technologies have enabled RIB to manage entire project lifecycles, ensuring that projects are completed on time, within budget, to high-quality standards and importantly while reducing carbon footprints. Our partnership with Building Transparency will expand our portfolio of software solutions, enabling us to continually propel the global industry forward toward achieving its sustainability targets,” concludes René Wolf, RIB CEO.

Sustainable solutions are at the heart of everything we do

With more than 550,000 users and 2,600 talents, RIB aims to connect people, processes and data in innovative ways. That includes supporting the development and availability of world-leading solutions that empower industry professionals to quantify, measure, report on and compare embodied carbon across the project lifecycle. In-progress development sees RIB’s solutions ultimately enabling better design and procurement decisions factoring in cost, time and carbon in order to mitigate and eliminate embodied carbon used across the life of a building. From planning to construction, to operation and maintenance, RIB is placing people, sustainability and industry best practices at the heart of everything it does.

Attachment

• RIB_PR_Backing Embodied Carbon Measurement Technology.pdf

Press Enquiries
Kim Immelman
kim.immelman@rib-software.com

GlobeNewswire Distribution ID 1000809463

May 11, 2023

• Late-breaking data presented from largest-ever randomized controlled multicenter clinical trial on optimizing patient safety during coronary procedures
• Philips-hosted symposiums and onsite trainings to empower better heart care through integrated imaging, devices, software, informatics and services

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing end-to-end cardiology solutions through the care pathway at the annual meeting for the European Association of Percutaneous Cardiovascular Interventions (EuroPCR, May 16-19, Paris, France) to deliver better heart care for patients with greater efficiency. The Philips cardiology portfolio addresses the need for integrating imaging, devices, software, informatics, and services at each point in the cardiac patient journey. Philips’ proven physiology technologies can enable interventionalists to perform ultra-low contrast percutaneous coronary intervention (ULC-PCI) procedures with greater confidence.

Late-breaking clinical sessions on evidence-based coronary imaging
In line with the company’s commitment to supporting its innovations with clinical evidence, Philips’ clinical partners will present new data during late-breaking sessions at EuroPCR that could help inform treatment for PCI patients.

• Dynamic coronary roadmap for contrast reduction trial (DCR4Contrast): Prof. Javier Escaned, Head of the Interventional Cardiology Section at Hospital Clinico San Carlos, Madrid Spain, will present results from the DCR4Contrast trial, the largest-ever randomized controlled clinical trial on this topic, which investigated the ability of Philips Dynamic Coronary Roadmap (DCR) to reduce the total iodinated contrast media volumes administered during percutaneous coronary intervention (PCI) procedures, compared to PCI performed without DCR guidance. The late-breaker presentation will take place on Tuesday, May 16 at 12:00 to 13:30 (CET) in Room Maillot. Prof. Escaned will also present the results from the DCR4Contrast trial and is available for questions during the EuroPCR 2023 Press Conference taking place on Tuesday 16 May from 08:05 – 09:15am CET in the Press Room on Level 3.
• iFR versus FFR-guided revascularization decision-making: Dr. Takayuki Warisawa, Interventional cardiologist at NTT Medical Center in Tokyo, Japan, will present new data on iFR versus FFR-guided revascularization decision-making in disease of the left main ventricle. The late-breaker presentation adds to a growing body of evidence showing iFR improves patient outcomes and optimizes procedural results. The session will take place on Tuesday 16 May from 12:00 to 13:00 CET in Room Maillot.
• DEFINE-FLAIR five-year follow-up: Prof. Javier Escaned will also present 5-year data from the DEFINE FLAIR clinical trial comparing patient outcomes using instant wave-free ratio (iFR) and fractional flow reserve (FFR) in the diagnosis and treatment of heart disease. The late-breaker presentation will take place on Thursday, May 18 from 15:15 to 16:45 CET in Room Maillot.
• Radiographic imaging validation and Evaluation for angio iFR (ReVEAL iFR): Dr. Yoshinobu Onuma will present the results of this multi-center, prospective, single-arm, open-label data collection with centralized off-line data analysis intended to demonstrate the diagnostic performance of angiographic-derived iFR single plane angiogram derived physiology model using the invasive physiological measures of both iFR and FFR as the reference standards. The late-breaker presentation will take place on Thursday, May 18 at 15:15 to 16:45 CET in Room Maillot.

More information on these sessions and the full EuroPCR 2023 program can be found here.

Highlight innovations from Philips’ cardiology portfolio on display at EuroPCR include Philips Image Guided Therapy System – Azurion, Philips Interventional Applications Platform – IntraSight, next to visualization solutions such as Philips Precision Guidance System – SyncVision, Philips Dynamic Coronary Roadmap, live echo and live X-ray fusion tool – EchoNavigator, Pressure Guide Wire – OmniWire and its intravascular ultrasound (IVUS) catheters. Next to this, Philips will showcase atherectomy solutions, such as RX PTCA Scoring Balloon Catheter – AngioSculpt Evo, and its coronary laser atherectomy catheter – ELCA.

Live expert-led training sessions, symposiums and in-booth displays will give physicians and media insights into the latest developments in optimizing ULC-PCI procedures. Philips will also hold IVUS Simulation Sessions on recognizing different types of calcified plaque by intravascular ultrasound (IVUS) and optical coherence tomography. In the Philips Training Village visitors can learn more about how Philips solutions support interventionalists in minimizing the contrast load for the patient and physicians, and in performing interventional procedures with clarity and confidence using solutions such as IVUS, iFR, FFR and laser, improving cardiac care experiences for staff and patients.

For a full calendar of Philips events, session registration and to learn more about cardiology solutions being showcased in Philips Booth #F20 at EuroPCR 2023, please visit our website.

For further information, please contact:

Joost Maltha
Philips Global Press Office
Tel: +31 6 10 55 8116
Email: joost.maltha@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

• Philips Omniwire
• Philips iFR
• Philips IVUS
• Philips Azurion
• Philips Dynamic Coronary Roadmap

GlobeNewswire Distribution ID 1000809437

VCI Global Limited applies to dual list on Upstream to tap into global audience who can invest using digital currency & traditional payments

KUALA LUMPUR, Malaysia, May 11, 2023 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) today announced that it has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex (“Horizon”) and MERJ Exchange Limited (“MERJ”).

The planned dual listing on Upstream is designed to provide VCI Global the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in NASDAQ-listed VCI Global.

Commenting on the application to list on Upstream Dato’ Victor Hoo, Chairman and Group Director of VCI Global, said, “Building shareholder value and increasing our liquidity is always a high priority for us as a Company. We believe a dual listing on Upstream will act as an excellent vehicle to reach an untapped international market of potential new shareholders.”

Approval to be listed on Upstream is subject to acceptance by MERJ. However, as an existing NASDAQ issuer, VCI Global may be eligible for an expedited listing process.

About VCI Global Limited

VCI Global is a multi-disciplinary consulting group with key advisory practices in the areas of business and technology. The Company provides business and boardroom strategy services, investor relation services, and technology consultancy services. Its clients range from small-medium enterprises and government-linked agencies to publicly traded companies across a broad array of industries. VCI Global operates solely in Malaysia, with clients predominantly from Malaysia, but also serves some clients from China, Singapore, and the US.

For more information on the Company, please log on to https://v-capital.co/.

About Upstream

Upstream, a MERJ Exchange Market (merj.exchange), is a fully regulated global stock exchange for digital securities and NFTs. Powered by Horizon’s proprietary blockchain-powered matching engine technology, the platform enables users to trade NFTs, and invest in securities for IPOs, crowdfunded companies, U.S. & international equities, and celebrity ventures using the Upstream app. For more information, please visit https://upstream.exchange/. Upstream is currently accepting applications to dual list at https://upstream.exchange/getlisted.

Disclaimers:

This press release shall not constitute an offer to sell securities or the solicitation of an offer to buy securities in any jurisdiction where such offer or solicitation is not permitted.

Upstream and issuers do not charge for share transfers, however, transfer agents may charge investors for share transfers. Such fees are standard in the industry and if a fee is required, the transfer agent will alert the investor of such charges and how to pay via credit card, check or wire.

NFTs have no royalties, equity ownership, or dividends. NFTs are for utility, collection, redemption or display purposes only. Anyone may buy and sell NFTs on Upstream.

* U.S. or Canadian-based citizen or permanent are not currently able to deposit, buy, or sell securities on Upstream. Note that U.S. or Canadian-based investors include those U.S. or Canadian citizens who may be domiciled overseas. All orders for sale are non-solicited by Upstream and a user’s decision to trade securities must be based on their own investment judgement.

Upstream is a MERJ Exchange market. MERJ Exchange is a licensed Securities Exchange, an affiliate of the World Federation of Exchanges, a National Numbering Agency and member of ANNA. MERJ supports global issuers of traditional and digital securities through the entire asset life cycle from issuance to trading, clearing, settlement, and registry. It operates a fair and transparent marketplace in line with international best practices and principles of operations of financial markets. Upstream does not endorse or recommend any public or private securities bought or sold on its app. Upstream does not offer investment advice or recommendations of any kind. All services offered by Upstream are intended for self-directed clients who make their own investment decisions without aid or assistance from Upstream. All customers are subject to the rules and regulations of their jurisdiction. By accessing the site or app, you agreed to be bound by its terms of use and privacy policy. Company and security listings on Upstream are only suitable for investors who are familiar with and willing to accept the high risk associated with speculative investments, often in early and development stage companies. There can be no assurance the valuation of any particular company’s securities is accurate or in agreement with the market or industry comparative valuations. Investors must be able to afford market volatility and afford the loss of their investment. Companies listed on Upstream are subject to significant ongoing corporate obligations including, but not limited to disclosure, filings, and notification requirements, as well as compliance with applicable quantitative and qualitative listing standards.

Forward-Looking Statements

This communication contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) difficulties in obtaining financing on commercially reasonable terms; (ii) changes in the size and nature of our competition; (iii) loss of one or more key executives or brand ambassadors; and (iv) changes in legal or regulatory requirements in the markets in which we operate. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

CONTACT INFORMATION:

Issued by Imej Jiwa Communications Sdn Bhd on behalf of VCI Global Limited
For media queries, please contact:

Chris Chuah
Email: chris@imejjiwa.com

GlobeNewswire Distribution ID 8837019

The following is an extract from the “Iveco Group 2023 First Quarter Results” press release. The complete press release can be accessed by visiting the media section of the Iveco Group corporate website: https://www.ivecogroup.com/media/corporate_press_releases or consulting the accompanying PDF:

Iveco Group consolidated revenues of €3.4 billion (up 11.5% year-on-year).
Adjusted EBIT of €162 million and adjusted net income of €63 million.
Net cash of Industrial Activities at €1.1 billion.
Full year 2023 Financial Guidance updated upward.

Consolidated revenues of €3,399 million, up 11.5%. Net revenues of Industrial Activities of €3,328 million, up 10.6%, mainly due to positive price realisation and higher volumes.

Adjusted EBIT of €162 million (€60 million increase compared to Q1 2022), with a 4.8% margin (up 150 bps compared to Q1 2022). Adjusted EBIT of Industrial Activities of €134 million (€82 million in Q1 2022), with a 4.0% margin (up 130 bps compared to Q1 2022): positive price realisation, higher volumes and better mix more than offset higher raw material and energy costs.

Adjusted net income of €63 million (€21 million increase compared to Q1 2022), which primarily excludes a negative after-tax impact of €44 million from the agreed acquisition of full ownership of Nikola Iveco Europe GmbH. Adjusted diluted earnings per share of €0.21 (up €0.06 compared to Q1 2022).

Financial expenses of €74 million (€34 million in Q1 2022), increasing mainly as a consequence of higher interest rates and the impact of hyperinflation accounting in Argentina and Türkiye.

Reported income tax expense of €24 million, with adjusted effective tax rate (adjusted ETR) of 28% reflecting different tax rates applied in the jurisdictions where the Group operates and some other discrete items.

Net cash of Industrial Activities at €1,103 million (€1,727 million at 31^st December 2022). Free cash flow of Industrial Activities negative for €593 million (€427 million lower compared to Q1 2022) primarily due to the impact on inventory level deriving from high demand, as well as component shortage and supply chain issues.

Available liquidity at €3,980 million as of 31^st March 2023, down €384 million from 31^st December 2022, including €2,051 million of undrawn committed facilities.

Attachment

• 20230511_PR_IVG_Q1_2023

GlobeNewswire Distribution ID 1000809387

Mont-Saint-Guibert, Belgium – May 10, 2023, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Christoph Eigenmann as Chief Commercial Officer. Christoph will oversee commercial activities globally, be responsible for sales and marketing in existing markets, and new market development.

Christoph brings a wealth of experience in medical technologies to Nyxoah. He spent over 20 years with Johnson & Johnson (J&J), where he oversaw commercial organizations in various geographies in Europe and the United States. He has extensive experience in managing orthopedic and neuro businesses in the German, Swiss and U.S. markets, including as Senior Vice President, Sales & Marketing for J&J’s close to $1B U.S. Spine franchise, and has led regional functions across EMEA and North America. Christoph holds a master’s degree in chemical engineering and biotechnology from the Swiss Federal Institute of Technology in Lausanne, Switzerland.

“We are excited to have Christoph join Nyxoah as we embark on our next phase of growth. Christoph’s years of experience in commercializing medical devices globally will be invaluable as Nyxoah prepares to enter the U.S. market and expands its commercial presence internationally,” commented Olivier Taelman, Nyxoah Chief Executive Officer.

“I am thrilled to be joining Nyxoah at this critical and exciting time. Hypoglossal nerve stimulation is a large and highly under-penetrated market, and Nyxoah’s novel approach provides a highly differentiated solution for patients, clinicians, and healthcare systems. I look forward to applying my long tenure of commercializing medical devices in the U.S. to ensuring Genio becomes a standard of care in OSA treatment,” added Christoph.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

• ENGLISH_CCO Appointment_FINAL

GlobeNewswire Distribution ID 1000809330